Supernus Pharmaceuticals | SUPN - Bénéfice Avant Impôts

Prix De L'Action
49.81
Variation Quotidienne
-0.87 -1.72%
Mensuellement
-0.80%
Annuel
57.63%
Q2 Prévisions
49.30




Bénéfice Avant Impôts Changement Date
Abbott USD 2.36B 178M 2025-12
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Canopy Growth CAD -62.26M 60.84M 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Novo Nordisk DKK 33.8B 3.23B 2025-06
Pacira USD 9.52M 11.45M 2025-09
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
United Therapeutics USD 444M 6M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12